Background: Blockchain is increasingly proposed to strengthen pharmaceutical traceability, anti-counterfeiting, and chain of custody in multi-actor supply chains, but the evidence base remains heterogeneous in technical rigor and operational clarity. Methods: We conducted a mapping review of Scopus and Web of Science to map publication patterns, identify dominant thematic configurations, and compare citation-salient studies across recurring solution profiles and operational design dimensions. The final corpus comprised 103 records. Results: The literature expanded rapidly from 2019 to 2025, with notable geographic concentration and dissemination mainly through technically focused outlets. Keyword analysis identified a core traceability theme, an implementation stream centered on smart contracts, Ethereum, and security, and additional streams involving vaccines and regulatory or credentialing concerns. Citation-salient studies clustered into implemented systems and prototypes, architecture or framework proposals, and contextual maturity or decision-layer evidence. Across these profiles, transferability depended less on platform choice than on governance and access-control assumptions, modular smart contract roles, and verifiable on-chain/off-chain data placement. Conclusions: Chain-of-custody semantics and evaluation methods remain inconsistently formalized, limiting cross-study comparability and the interpretability of operational claims. Benchmark-oriented assessments and minimal reporting standards specifying governance parameters, logistics scope and checkpoints, workload, measurement conditions, and concrete evidence artifacts are needed.
Díaz et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: